Correlation Between Cullinan Oncology and Immuneering Corp
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Immuneering Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Immuneering Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Immuneering Corp, you can compare the effects of market volatilities on Cullinan Oncology and Immuneering Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Immuneering Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Immuneering Corp.
Diversification Opportunities for Cullinan Oncology and Immuneering Corp
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cullinan and Immuneering is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Immuneering Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immuneering Corp and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Immuneering Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immuneering Corp has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Immuneering Corp go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Immuneering Corp
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Immuneering Corp. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 1.35 times less risky than Immuneering Corp. The stock trades about -0.2 of its potential returns per unit of risk. The Immuneering Corp is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest 221.00 in Immuneering Corp on November 3, 2024 and sell it today you would lose (27.00) from holding Immuneering Corp or give up 12.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Immuneering Corp
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Immuneering Corp |
Cullinan Oncology and Immuneering Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Immuneering Corp
The main advantage of trading using opposite Cullinan Oncology and Immuneering Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Immuneering Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immuneering Corp will offset losses from the drop in Immuneering Corp's long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| Immuneering Corp vs. Pmv Pharmaceuticals | Immuneering Corp vs. Cullinan Oncology LLC | Immuneering Corp vs. Enliven Therapeutics | Immuneering Corp vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |